ficusin has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bari, SB; Deshmukh, PK; Donda, ST; Firke, SD; Patil, DA; Patil, PO | 1 |
| Di Lucente, J; Hilt, S; Jenkins, DP; Jin, LW; Kim, K; Levey, AI; Maezawa, I; Nguyen, HM; Rangaraju, S; Singh, V; Wulff, H | 1 |
1 review(s) available for ficusin and Alzheimer Disease
| Article | Year |
|---|---|
A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease.
Topics: Alzheimer Disease; Coumarins; Depression; Drug Design; Humans; Models, Molecular; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Structure-Activity Relationship | 2013 |
1 other study(ies) available for ficusin and Alzheimer Disease
| Article | Year |
|---|---|
Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Animals, Newborn; Avoidance Learning; Cells, Cultured; Disease Models, Animal; Exploratory Behavior; Ficusin; Gene Expression Regulation; Kv1.3 Potassium Channel; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Mutation; Peptide Fragments; Potassium Channel Blockers; Presenilin-1; Shab Potassium Channels | 2018 |